No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
478 |
4. Check minimum number of events
Min. number of events
3
|
478 |
5. Include endpointsNone |
478 |
6. Filter based on genotype QC (FinnGen only) |
478 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Biological medicines for asthma
based on the number of shared cases.
Similar with more cases:
- Any reimbursement code in KELA
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1297 | 753 | 538 |
| Only index persons | 1280 | 749 | 531 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 50.20 | 49.28 | 51.58 |
| Only index persons | 50.32 | 49.31 | 51.75 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 478 | 298 | 180 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.08 |
| Median age at first event (years) | 55.71 | 55.44 | 56.17 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 318
- Matched controls
- 3180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R03DC03
ATC
montelukast; oral
41.9
169.8
263
325
R03DX05
ATC
omalizumab; parenteral
+∞
128.0
114
*
344
Kela drug reimbursment
Omalizumab
+∞
128.0
114
*
R03BB04
ATC
tiotropium bromide; inhalant
35.4
126.4
171
101
H02AB06
ATC
prednisolone; systemic
62.5
126.3
307
981
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
18.7
115.5
227
373
J45.0
ICD-10 Finland
Predominantly allergic asthma
23.6
109.4
171
149
ZX112
NOMESCO Finland
Subcutaneous
82.3
105.7
116
22
395
Kela drug reimbursment
Dupilumab
+∞
98.1
89
*
D11AH05
ATC
dupilumab; topical
+∞
96.9
88
*
J45.9
ICD-10 Finland
Asthma, unspecified
14.2
94.0
198
330
R03AK08
ATC
formoterol and beclometasone; inhalant
34.3
88.4
117
53
3028
Kela drug reimbursment
Mepolizumab
+∞
87.6
80
*
297
Kela drug reimbursment
NA
+∞
87.6
80
*
R03DX09
ATC
mepolizumab; parenteral
+∞
85.3
78
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
41.1
81.2
102
36
J45.1
ICD-10 Finland
Nonallergic asthma
17.6
73.2
123
110
R06AX27
ATC
desloratadine; oral
8.7
68.1
218
639
R03DA04
ATC
theophylline; systemic, rectal
27.0
61.4
86
43
J46
ICD-10 Finland
Status asthmaticus
32.4
59.6
79
32
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
14.7
56.1
100
96
3027
Kela drug reimbursment
Benralizumab
+∞
54.8
51
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
9.1
53.9
131
228
R03DX10
ATC
benralizumab; systemic
+∞
53.7
50
*
R03BA08
ATC
ciclesonide; inhalant
10.8
51.7
109
146
UDH02
NOMESCO Finland
Rhinopharyngoscopy
13.1
51.6
97
103
R03AC02
ATC
salbutamol; inhalant
7.8
51.6
268
1299
J32.4
ICD-10 Finland
Chronic pansinusitis
41.8
51.6
64
19
251
Kela drug reimbursment
NA
+∞
50.4
47
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
23.3
50.1
73
40
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.8
49.9
105
139
R01AD08
ATC
fluticasone; nasal
5.9
46.9
191
649
TDM10
NOMESCO Finland
Puncture of maxillary antrum
16.6
46.5
77
60
R03BA02
ATC
budesonide; inhalant
6.7
46.3
144
347
R06AE09
ATC
levocetirizine; oral
7.0
45.8
135
301
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
31.2
44.4
59
23
C01CA24
ATC
epinephrine; parenteral
10.3
44.2
94
124
XQ800
NOMESCO Finland
Prick test
8.9
44.2
104
164
L50.9
ICD-10 Finland
Urticaria, unspecified
17.7
43.0
69
49
R06AE07
ATC
cetirizine; oral
5.4
42.3
231
1045
R03AK07
ATC
formoterol and budesonide; inhalant
6.0
42.0
147
401
R03AC13
ATC
formoterol; inhalant
14.7
42.0
73
63
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
32.4
39.6
52
19
L50.1
ICD-10 Finland
Idiopathic urticaria
65.2
39.5
45
8
D11AH01
ATC
tacrolimus; topical
38.3
38.9
49
15
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
70.7
38.2
43
7
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.7
38.1
78
94
J45.8
ICD-10 Finland
Mixed asthma
20.8
38.0
57
33
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
16.1
38.0
63
48
J45
ICD-10 Finland
Asthma
7.5
37.5
99
181
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
25.6
37.1
52
24
R03AC12
ATC
salmeterol; inhalant
16.9
37.0
60
43
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
12.8
36.9
68
66
R03AK11
ATC
formoterol and fluticasone; inhalant
22.2
36.8
54
29
J33.0
ICD-10 Finland
Polyp of nasal cavity
17.4
36.8
59
41
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
11.4
36.2
71
78
L20.0
ICD-10 Finland
Besnier prurigo
8.9
35.5
81
117
L04AD01
ATC
ciclosporin; systemic
26.1
35.2
49
22
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
12.5
34.9
65
64
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.5
34.8
193
816
R96
ICPC
Asthma
8.0
33.7
83
135
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
15.6
33.5
56
43
R06AX22
ATC
ebastine; oral
5.2
33.1
126
359
H02AB07
ATC
prednisone; oral
6.2
33.0
101
222
L50.8
ICD-10 Finland
Other urticaria
18.7
32.9
51
32
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
13.9
31.9
56
48
WZC30
NOMESCO Finland
Teaching
6.2
31.5
96
208
J33.8
ICD-10 Finland
Other polyp of sinus
17.2
31.3
50
34
D11AX14
ATC
[U] tacrolimus; topical
57.7
31.0
36
7
R03BA05
ATC
fluticasone; inhalant
4.8
30.7
126
383
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.5
29.9
86
172
H02AB09
ATC
hydrocortisone; systemic
21.4
29.2
43
23
D11AH02
ATC
pimecrolimus; topical
114.1
29.2
31
*
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.3
28.7
137
477
H02AB04
ATC
methylprednisolone; systemic
5.1
28.1
102
268
D07AB08
ATC
desonide; topical
5.8
27.4
86
190
E0000UV
ATC
NA
3.6
26.0
182
857
D07AC01
ATC
betamethasone; topical
3.7
26.0
157
658
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
39.3
25.7
32
9
R03BA01
ATC
beclometasone; inhalant
4.8
25.6
98
269
R01AD12
ATC
fluticasone furoate; nasal
3.6
25.6
165
726
49300
ICD-8 Finland
Asthma, bronchiale
19.4
25.1
38
22
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
24.5
135
515
J01MA14
ATC
moxifloxacin; systemic
6.6
24.5
67
123
R01AD09
ATC
mometasone; nasal
3.4
24.2
202
1067
D07AA02
ATC
hydrocortisone; topical
4.6
23.7
95
271
UDM02
NOMESCO Finland
Sinoscopy
12.2
22.9
42
39
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
6.8
22.6
60
105
L50.3
ICD-10 Finland
Dermatographic urticaria
20.3
22.2
33
18
XG410
NOMESCO Finland
Flow-volume spirometry
9.1
22.2
48
61
3DX05
NOMESCO Finland
NA
123.5
21.9
23
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
28.8
21.8
29
11
R06AX13
ATC
loratadine; oral
4.0
21.4
102
338
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.2
21.3
219
1293
S01GX01
ATC
cromoglicic acid; ophthalmic
3.6
21.1
117
439
R03AC03
ATC
terbutaline; inhalant
4.2
21.0
92
282
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.0
20.6
97
317
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.5
20.2
118
459
R06.0
ICD-10 Finland
Dyspnoea
3.6
20.2
109
398
J01FA09
ATC
clarithromycin; systemic
3.1
20.0
153
724
R06AX26
ATC
fexofenadine; oral
6.3
20.0
56
105
J01FA10
ATC
azithromycin; systemic
3.2
19.8
240
1547
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
4.6
19.8
75
199
J01FA06
ATC
roxithromycin; oral
3.0
19.6
171
882
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
33.7
19.6
25
8
D02AE01
ATC
carbamide; topical
6.1
19.3
55
105
D07AB02
ATC
hydrocortisone butyrate; topical
3.3
19.2
129
551
TQW80
NOMESCO Finland
Local dermatologic skincare
12.5
19.0
34
30
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.1
19.0
48
78
D72.1
ICD-10 Finland
Eosinophilia
74.5
18.9
21
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
106.4
18.8
20
*
134
Kela drug reimbursment
General erythroderma
201.3
18.7
19
*
E000002
ATC
NA
4.6
18.7
71
188
R01AD05
ATC
budesonide; nasal
5.2
18.5
61
139
D11AX15
ATC
[U] pimecrolimus; topical
55.9
18.2
21
*
J31.0
ICD-10 Finland
Chronic rhinitis
5.6
17.7
54
112
D07BA04
ATC
hydrocortisone and antiseptics; topical
4.3
16.8
68
190
R02
ICPC
Shortness of breath/dyspnoea
4.3
16.4
65
178
J01AA02
ATC
doxycycline; systemic
3.3
16.2
269
1978
TGC00
NOMESCO Finland
Bronchial lavation
13.2
16.2
28
23
E000001
ATC
NA
3.2
16.2
102
409
ZXA10
NOMESCO Finland
Bilateral
3.5
15.9
84
293
E000003
ATC
NA
7.1
15.8
39
61
DHB20
NOMESCO Finland
Polypectomy of internal nose
14.0
15.5
26
20
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.5
15.5
82
287
J47
ICD-10 Finland
Bronchiectasis
18.9
15.4
23
13
D02AX
ATC
Other emollients and protectives
8.1
15.2
34
46
R03DC01
ATC
zafirlukast; oral
16.1
15.1
24
16
XQ802
NOMESCO Finland
Epicutan test
6.4
14.6
39
68
R01AD11
ATC
triamcinolone; nasal
4.5
14.6
54
138
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.4
14.5
55
144
DPA30
NOMESCO Finland
Sphenotomy
28.7
14.4
19
7
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
20.3
14.4
21
11
J33.9
ICD-10 Finland
Nasal polyp, unspecified
20.3
14.4
21
11
E000007
ATC
NA
5.5
13.7
41
83
R01AD01
ATC
beclometasone; nasal
3.2
13.6
83
320
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
13.3
131
676
A02BC02
ATC
pantoprazole; systemic
2.5
13.2
217
1472
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
17.7
13.2
20
12
DHB50
NOMESCO Finland
Turbinoplasty
9.3
12.8
26
30
J01FF01
ATC
clindamycin; systemic
2.7
12.4
107
507
R03BC03
ATC
nedocromil; inhalant
4.6
12.2
43
104
Z51.6
ICD-10 Finland
Desensitization to allergens
10.7
12.2
23
23
N05BB01
ATC
hydroxyzine; systemic
4.5
12.0
43
106
D09AB01
ATC
zinc bandage without supplements; topical
10.2
12.0
23
24
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
10.2
12.0
23
24
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
11.8
41
98
J01FA15
ATC
telithromycin; oral
3.4
11.8
61
208
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
31.3
11.7
15
5
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
67.5
11.7
13
*
J34.2
ICD-10 Finland
Deviated nasal septum
5.1
11.7
37
80
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
11.7
137
766
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.5
11.6
113
575
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
11.5
49
142
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
124.3
11.5
12
*
J30.3
ICD-10 Finland
Other allergic rhinitis
6.0
11.4
31
56
N02AX02
ATC
tramadol; systemic, rectal
2.3
11.2
148
873
XQ848
NOMESCO Finland
Dermatological photography
10.6
11.2
21
21
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
29.2
10.8
14
5
L26
ICD-10 Finland
Exfoliative dermatitis
62.1
10.7
12
*
J01DA01
ATC
[U] cefalexin; systemic
2.2
10.5
214
1522
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
113.6
10.5
11
*
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
12.6
10.5
18
15
D07AC13
ATC
mometasone; topical
2.4
10.3
111
585
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.6
10.2
19
19
L50.0
ICD-10 Finland
Allergic urticaria
6.0
10.1
27
48
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
17.4
10.0
15
9
A02BC05
ATC
esomeprazole; systemic
2.2
9.8
138
821
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
9.6
128
739
R03BB01
ATC
ipratropium bromide; inhalant
7.0
9.6
23
35
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
5.7
9.6
27
51
DJD20
NOMESCO Finland
Plastic repair of septum of nose
5.7
9.6
27
51
J02AC01
ATC
fluconazole; systemic
2.2
9.6
149
924
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
12.9
9.5
16
13
WW200
NOMESCO Finland
Immunization
5.8
9.4
26
48
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
9.4
140
852
J01DB01
ATC
cefalexin; oral
2.6
9.4
275
2252
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
9.3
138
838
T78.4
ICD-10 Finland
Allergy, unspecified
4.4
9.3
33
81
R06AX18
ATC
acrivastine; oral
6.4
9.1
23
38
D07CC01
ATC
betamethasone and antibiotics; topical
3.0
9.1
55
208
D07AD01
ATC
clobetasol; topical
2.7
9.0
64
267
L27.2
ICD-10 Finland
Dermatitis due to ingested food
13.0
9.0
15
12
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
8.9
169
1129
D07AC14
ATC
methylprednisolone aceponate; topical
4.7
8.8
29
66
L04AX01
ATC
azathioprine; systemic
4.4
8.8
31
76
A07AA02
ATC
nystatin; oral
4.3
8.6
31
77
G47.3
ICD-10 Finland
Sleep apnoea
2.4
8.5
81
395
A02BC01
ATC
omeprazole; systemic
2.3
8.5
91
472
E000006
ATC
NA
3.7
8.5
37
110
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.5
8.5
21
34
4AC06
NOMESCO Finland
NA
92.4
8.5
9
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
92.4
8.5
9
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
8.3
73
340
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
5.0
8.3
26
56
R05
ICD-10 Finland
Cough
2.5
8.2
71
331
L50
ICD-10 Finland
Urticaria
7.1
8.2
19
28
WQ000
NOMESCO Finland
Hyposensibilisation
12.1
8.2
14
12
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
34.3
8.1
10
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
10.4
8.1
15
15
N02BE01
ATC
paracetamol; systemic, rectal
2.4
8.0
273
2273
R06.2
ICD-10 Finland
Wheezing
4.1
7.9
30
79
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
7.9
81
408
S88
ICPC
Dermatitis contact/allergic
9.8
7.9
15
16
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
7.7
7.8
17
23
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
15.5
7.8
12
8
A02BA02
ATC
ranitidine; systemic
2.4
7.5
67
317
A01AB09
ATC
miconazole; local oral
3.3
7.5
37
122
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
13.8
7.4
12
9
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.2
7.4
27
69
T78.3
ICD-10 Finland
Angioneurotic oedema
11.2
7.4
13
12
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.1
7.4
96
540
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
6.5
7.4
18
29
ZX110
NOMESCO Finland
Intracutaneous
+∞
7.3
7
*
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
6.8
7.2
17
26
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.5
7.2
20
38
J04BA02
ATC
dapsone; oral
20.6
7.2
10
5
M05BA04
ATC
alendronic acid; oral
4.2
7.2
26
66
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.7
7.1
30
87
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
12.4
7.1
12
10
J01DC02
ATC
cefuroxime; systemic
3.5
7.0
31
94
R51.80
ICD-10 Finland
Headache
2.4
6.9
60
279
ZXC95
NOMESCO Finland
Use of surgical navigator
11.3
6.9
12
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.8
89
496
J01MA12
ATC
levofloxacin; systemic
2.4
6.8
60
280
D07XC01
ATC
betamethasone, combinations; topical
2.9
6.8
42
160
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
6.7
33
109
S01GX02
ATC
levocabastine; ophthalmic
3.2
6.6
33
110
L04AA01
ATC
[U] ciclosporin; systemic
7.1
6.6
15
22
J37.0
ICD-10 Finland
Chronic laryngitis
5.9
6.5
17
30
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.3
6.5
23
57
R49.08
ICD-10 Finland
Other specified dysphonia
7.7
6.5
14
19
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.2
6.5
32
106
R06AE08
ATC
NA
14.7
6.4
10
7
S98
ICPC
Urticaria
14.7
6.4
10
7
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
6.4
78
424
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.4
6.4
18
35
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
11.3
6.3
11
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.7
6.3
26
75
L95.8
ICD-10 Finland
Other vasculitis limited to skin
+∞
6.3
6
*
TQX05
NOMESCO Finland
Skin puncture, unspecified location
+∞
6.3
6
*
3DX08
NOMESCO Finland
NA
+∞
6.3
6
*
R03BB05
ATC
aclidinium bromide; inhalant
+∞
6.3
6
*
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
27.3
6.3
8
*
WX722
NOMESCO Finland
PEEP
4.6
6.2
20
46
R01AD
ATC
Corticosteroids
8.9
6.1
12
14
D07AB01
ATC
clobetasone; topical
4.7
6.1
19
42
J01DA08
ATC
[U] cefaclor; oral
2.3
6.1
55
260
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
372
256
62.02
307.65
2.9
1.3
u/ml
1100.3
228.6
5.05
365
231
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
143
27
75.14
259.44
1.6
1.1
u/ml
1.0
0.2
1.71
105
11
(42870588) Differential panel, method unspecified - Blood
376
1246
10.46
123.30
8.9
5.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
461
1970
38.68
116.77
10.5
5.6
e9/l
0.6
0.6
6.72
449
1730
(3006315) Basophils [#/volume] in Blood
461
1976
38.48
116.20
10.5
5.6
e9/l
0.0
0.0
4.14
449
1737
(3013115) Eosinophils [#/volume] in Blood
466
2041
52.11
114.53
11.4
5.9
e9/l
0.3
0.2
12.70
456
1819
(3019198) Lymphocytes [#/volume] in Blood
461
2032
36.67
111.07
10.6
5.6
e9/l
2.1
2.0
0.46
450
1821
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
99
83
14.78
101.87
1.3
1.1
u/ml
4.8
1.0
1.07
65
31
(3023419) Bacteria identified in Sputum by Culture
78
42
22.00
100.79
3.0
2.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
93
76
14.95
97.00
1.2
1.0
u/ml
3.4
10.3
1.46
68
38
(3013650) Neutrophils [#/volume] in Blood by Automated count
462
2289
31.42
90.94
11.1
8.8
e9/l
4.3
4.0
2.85
449
2015
(3010726) Horse dander IgE Ab [Units/volume] in Serum
85
68
14.99
89.54
1.3
1.0
u/ml
4.2
4.7
0.07
36
15
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
111
135
10.41
88.44
1.8
1.7
titre
84.0
197.5
—
5
8
(3036481) Cortisol [Moles/volume] in Serum or Plasma
179
385
6.83
85.86
3.2
1.9
nmol/l
262.2
374.3
12.34
174
356
(3008401) Mugwort IgE Ab [Units/volume] in Serum
75
72
12.17
70.08
1.3
1.1
u/ml
2.0
0.8
0.55
51
29
(3002179) Metamyelocytes/100 leukocytes in Blood
134
285
6.14
63.35
4.2
4.4
%
0.3
0.4
0.35
29
64
(3025159) Blasts/100 leukocytes in Blood
131
274
6.21
63.01
4.6
4.7
%
0.0
0.0
0.01
30
63
(3014133) Dog dander IgE Ab [Units/volume] in Serum
65
59
12.59
62.81
1.2
1.0
u/ml
10.1
3.4
1.38
45
20
(3021440) Promyelocytes/100 leukocytes in Blood
134
288
6.08
62.60
4.6
4.7
%
0.1
0.2
0.42
31
77
(4010399)
125
255
6.28
61.63
2.2
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
137
312
5.75
59.89
4.6
4.5
%
0.5
0.9
0.99
32
90
(3023430) Cat dander IgE Ab [Units/volume] in Serum
60
53
12.80
58.90
1.2
1.0
u/ml
9.6
4.3
1.01
44
17
(3005719) IgG [Mass/volume] in Serum or Plasma
130
305
5.48
54.58
2.8
2.3
g/l
9.9
10.7
1.38
124
278
(3028192) IgG subclass 2 [Mass/volume] in Serum
50
45
12.29
48.30
1.4
1.3
g/l
2.7
2.8
0.04
39
33
(3024139) IgG subclass 3 [Mass/volume] in Serum
50
45
12.29
48.30
1.4
1.3
g/l
0.3
0.3
0.31
39
34
(4062490)
50
45
12.29
48.30
1.4
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
50
45
12.29
48.30
1.4
1.3
g/l
6.1
7.5
1.28
39
34
(3007853) Bacteria identified in Skin by Aerobe culture
147
425
4.55
47.29
2.5
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
177
588
4.19
47.24
1.4
1.4
titre
336.7
486.0
0.81
24
127
(3024980) IgG subclass 4 [Mass/volume] in Serum
58
70
9.29
45.51
1.5
1.9
g/l
1.3
0.8
1.12
46
58
(40760892) CBC W Ordered Manual Differential panel - Blood
236
986
3.75
44.61
8.0
4.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
327
1758
3.72
40.40
13.6
8.2
e9/l
0.0
0.0
0.59
309
1432
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
53
67
8.77
39.99
3.7
4.3
%
57.1
56.1
0.16
53
67
(3013707) Erythrocyte sedimentation rate by Westergren method
438
2903
7.08
39.83
5.7
3.8
mm/h
8.9
9.7
0.99
429
2700
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
32
18
18.98
39.77
1.1
1.0
u/ml
11.4
16.4
—
14
6
(3030905) Polymorphonuclear cells [#/volume] in Blood
51
65
8.66
38.19
3.5
3.8
e9/l
4.6
4.4
0.20
51
65
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
45
52
9.45
36.34
1.2
1.0
u/ml
0.6
0.8
0.11
25
11
(3028026) IgM [Mass/volume] in Serum or Plasma
94
244
4.55
33.93
1.5
1.6
g/l
1.0
1.5
1.62
88
225
(3000492) Spirometry study
130
428
3.80
33.88
2.2
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
48
66
7.97
33.68
1.4
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
37
5
79.79
33.35
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
133
466
3.57
31.33
2.1
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
27
18
15.84
30.74
1.4
1.1
g/l
0.3
0.3
0.31
21
13
(3042631) Mycobacterium sp identified in Specimen
37
41
9.70
30.74
3.7
3.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
23
11
21.92
30.47
4.7
6.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
55
98
6.21
30.31
3.3
2.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
416
2916
4.29
28.44
7.4
7.3
u/l
70.4
76.3
4.08
405
2748
(44813793)
31
30
10.98
28.29
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
67
153
4.93
28.10
1.4
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
22
14
16.42
25.54
1.1
1.1
u/ml
1.5
1.1
—
14
6
(3042936) Bacteria identified in Isolate by Culture
131
517
3.11
24.82
1.9
2.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
24
20
12.58
24.01
1.1
1.0
u/ml
7.5
4.6
—
12
6
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
21
16
13.68
22.10
1.4
1.3
ug/l
8.6
8.4
0.06
21
16
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
30
40
7.94
21.45
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
167
829
2.56
19.85
3.8
4.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
75
250
3.37
18.47
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
116
496
2.77
18.47
2.3
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
32
8.19
18.45
5.2
3.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
170
883
2.44
18.03
1.5
1.4
g/l
2.1
2.4
1.25
130
569
(4015189)
24
9
27.97
17.98
1.7
5.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
124
561
2.63
17.58
2.6
3.5
mmol/l
0.8
0.8
0.22
119
531
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
250
1562
2.26
16.94
2.7
2.3
nmol/l
77.8
75.1
0.78
237
1419
(3003327) Ova and parasites identified in Stool by Light microscopy
50
134
4.05
16.93
2.0
1.6
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
22
27
8.49
16.76
1.2
1.0
u/ml
4.0
0.3
—
15
6
(40758558) Short blood count panel - Blood
178
971
2.33
16.65
8.5
6.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
23
9.03
16.00
1.2
2.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
21
8
27.36
15.71
1.2
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
160
866
2.27
14.96
2.0
1.7
mg/l
0.8
1.0
0.83
122
646
(3020874) Milk IgE Ab [Units/volume] in Serum
21
28
7.80
14.94
1.2
1.0
u/ml
18.2
0.1
—
13
10
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
23
8.56
14.60
1.2
2.2
%
14.2
11.6
0.38
14
12
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
466
4032
7.20
13.94
18.8
11.4
mg/l
14.3
21.4
6.77
421
3091
(40761536) Microorganisms panel - Urine sediment
79
318
2.78
13.87
3.8
3.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
25
44
5.94
13.81
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
22
35
6.54
13.39
1.2
2.0
e9/l
1.6
1.3
0.69
16
16
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
355
2.66
13.39
2.0
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
28
57
5.16
13.27
4.4
3.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
36
95
4.02
12.41
1.1
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
81
350
2.58
12.30
2.1
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
40
116
3.67
12.09
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
387
3096
2.31
11.86
4.6
3.9
pmol/l
14.7
14.5
0.88
365
2863
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
204
1310
1.97
11.52
3.6
3.0
ng/l
24.3
29.1
0.31
125
782
(3032080) INR in Blood by Coagulation assay
203
1302
1.97
11.50
6.8
6.3
inr
1.1
1.1
0.14
80
402
(3037467) Urinalysis macro (dipstick) panel - Urine
344
2652
2.06
11.26
4.5
3.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
75
327
2.53
11.14
3.0
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
218
1449
1.93
10.98
3.7
4.7
g/l
36.2
36.5
0.45
207
1359
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
272
1947
1.92
10.91
4.8
6.4
umol/l
9.2
10.9
3.58
262
1839
(3027315) Oxygen [Partial pressure] in Blood
27
64
4.41
10.70
5.3
2.9
kpa
8.7
9.1
0.48
27
64
(3012501) Base excess in Blood by calculation
27
64
4.41
10.70
5.3
2.9
mmol/l
2.5
2.6
0.08
20
41
(3013290) Carbon dioxide [Partial pressure] in Blood
27
64
4.41
10.70
5.3
2.9
kpa
4.9
4.9
0.13
27
64
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
469
4317
5.59
10.36
13.2
9.5
u/l
27.7
27.9
0.10
463
4199
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
62
4.38
10.22
1.4
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
32
90
3.74
10.10
1.1
1.2
—
1.0
—
0
6
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
59
4.42
9.96
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
59
4.42
9.96
1.4
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
240
1683
1.86
9.93
5.2
6.8
mmol/l
1.2
1.2
0.04
184
1440
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
222
1523
1.85
9.82
5.8
5.9
mmol/l
1.2
1.2
0.53
209
1395
(3023520) Reticulocytes [#/volume] in Blood
54
213
2.73
9.77
2.6
2.9
e9/l
72.3
76.8
0.41
41
160
(3026493) Urate [Moles/volume] in Serum or Plasma
156
959
1.93
9.68
2.9
2.4
umol/l
334.3
6707.4
3.76
142
847
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
38
125
3.22
9.46
1.1
1.2
—
3.0
—
0
16
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
45
4.84
9.38
1.3
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
62
4.20
9.36
1.3
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
135
802
1.95
9.20
3.4
2.8
ng/l
424.1
687.4
1.93
117
656
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
29
82
3.70
9.09
1.4
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
115
649
2.02
9.06
2.2
2.4
mosm/kgh2o
597.1
564.8
0.73
102
550
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
197
2.72
9.06
3.2
3.0
mmol/l
1.1
1.3
0.14
41
141
(3023103) Potassium [Moles/volume] in Serum or Plasma
455
4053
3.55
9.05
17.6
12.6
mmol/l
3.9
3.9
7.05
449
3940
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
187
1244
1.83
8.92
3.3
2.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
19
39
5.03
8.91
2.0
1.8
%
90.3
91.7
0.62
19
39
(3009343) pH of Capillary blood
51
206
2.65
8.81
3.2
2.9
ph
7.4
7.4
—
10
22
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
120
3.16
8.78
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
155
980
1.86
8.66
1.7
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
281
2127
1.78
8.52
5.1
4.6
mmol/l
6.5
6.5
0.03
267
1969
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
0
+∞
8.35
1.1
0.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
146
2.90
8.35
1.6
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
54
4.22
8.35
3.2
2.4
%
19.0
17.1
—
10
23
(3017143) Hepatitis C virus Ab [Presence] in Serum
104
582
2.01
8.33
1.3
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
96
522
2.05
8.33
1.3
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
160
1035
1.82
8.24
3.1
2.8
e6/l
17.5
34.1
1.33
133
784
(3019550) Sodium [Moles/volume] in Serum or Plasma
452
4045
3.16
8.23
17.4
12.5
mmol/l
139.9
139.7
0.79
445
3941
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
64
3.90
8.17
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
55
4.14
8.15
1.5
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
425
3699
2.34
8.14
5.4
4.6
mu/l
1.8
2.1
0.60
407
3450
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
94
3.34
8.08
2.2
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
17
7.21
8.03
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
65
3.83
8.00
1.1
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
119
707
1.91
7.98
2.4
2.3
e6/l
4.5
6.4
0.78
105
624
(3024731) MCV [Entitic volume]
478
4588
+∞
7.93
28.8
16.9
fl
90.6
90.5
0.34
478
4538
(3035941) MCH [Entitic mass]
478
4588
+∞
7.93
28.8
16.9
pg
30.1
30.2
1.12
478
4537
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
80
3.52
7.92
1.5
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
345
2.21
7.80
1.4
1.3
iu/ml
100.6
169.3
1.04
24
144
(3000963) Hemoglobin [Mass/volume] in Blood
478
4591
+∞
7.75
29.1
17.0
g/l
139.5
137.5
2.82
478
4541
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
192
1332
1.74
7.67
1.9
1.8
pmol/l
98.1
96.9
0.12
115
682
(3018418) pH of Serum or Plasma
155
1015
1.78
7.55
3.2
3.8
ph
7.4
7.4
0.26
47
184
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
54
4.02
7.51
1.4
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
41
4.52
7.49
1.3
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
16
33
4.98
7.46
1.1
1.2
—
72.2
—
0
5
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
56
256
2.35
7.45
3.2
3.4
mmol/l
1.2
1.2
0.10
51
232
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
431
3805
2.35
7.43
15.2
10.3
ml/min/173m2
89.3
88.3
0.49
391
3104
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
134
846
1.81
7.35
2.4
1.9
mg/l
2.8
3.0
0.49
126
727
(3008536) Aspergillus sp Ab [Presence] in Serum
11
7
16.04
7.26
1.5
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
11
16
7.01
7.18
2.3
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
180
1246
1.71
7.13
3.8
3.2
e6/l
19.3
84.2
1.68
140
850
(3015377) Calcium [Moles/volume] in Serum or Plasma
169
1154
1.72
7.01
2.0
3.3
mmol/l
2.3
2.4
0.94
154
1020
(3035350) Ketones [Presence] in Urine by Test strip
252
1915
1.67
6.96
3.4
3.2
estimate
0.0
0.0
0.00
82
351
(3029937) Albumin [Presence] in Urine by Test strip
154
1028
1.73
6.92
3.5
3.4
estimate
0.0
0.0
0.69
83
359
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
157
1054
1.73
6.91
2.0
2.1
u/l
143.4
235.2
0.79
149
1005
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
151
1006
1.73
6.81
1.4
1.3
u/ml
1.7
1.7
0.00
46
295
(3022313) Gas panel - Capillary blood
39
157
2.62
6.79
3.1
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
20
54
3.82
6.70
1.4
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
142
935
1.74
6.66
3.0
2.7
e6/l
0.3
0.4
0.48
116
690
(36304419) Bacteria [Presence] in Urine
141
928
1.74
6.62
2.9
2.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
43
184
2.47
6.61
4.9
7.0
mmol/l
24.9
24.8
0.16
43
184
(3027945) Reticulocytes/100 erythrocytes in Blood
61
304
2.15
6.60
2.1
2.8
%
1.7
1.8
0.52
61
279
(3021879) Hepatitis B virus core Ab [Presence] in Serum
70
373
2.03
6.35
1.3
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
22
5.57
6.32
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
26
5.11
6.26
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
211
1563
1.63
6.23
2.0
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
248
1919
1.61
6.07
4.5
4.4
estimate
0.0
0.0
0.00
84
366
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
167
1180
1.64
5.89
2.3
2.6
u/l
52.9
55.7
0.67
150
1089
(3009261) Glucose [Presence] in Urine by Test strip
249
1938
1.59
5.88
3.5
3.2
estimate
0.0
0.0
0.21
84
350
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
20
5.61
5.83
2.0
3.4
u/ml
352.9
708.5
1.01
11
20
(21491868) Cryoglobulin [Mass/volume] in Serum
11
20
5.61
5.83
1.1
1.1
g/l
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
31
121
2.67
5.75
1.8
2.2
mg/l
8.7
11.3
1.97
31
112
(3013512) EKG study
144
986
1.66
5.72
3.7
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
37
159
2.44
5.65
1.7
2.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
9
7
13.07
5.60
1.2
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
136
922
1.66
5.59
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
29
4.58
5.54
1.2
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
67
3.23
5.53
1.1
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
5
16.24
5.42
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
113
736
1.70
5.38
1.3
1.3
u/ml
13.4
8.9
0.23
40
317
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
63
3.27
5.38
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
114
2.64
5.31
1.7
1.8
g/l
3.6
3.8
0.57
19
84
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
114
2.64
5.31
1.7
1.8
g/l
6.9
7.2
0.55
20
94
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
114
2.64
5.31
1.7
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
26
4.71
5.28
3.7
1.9
pg
31.2
33.2
0.92
12
26
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
31
4.28
5.12
1.4
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
9
10.16
5.04
1.2
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
96
609
1.72
5.01
3.3
3.4
ng/l
18.8
554.0
1.92
57
409
(3019060) Gas panel - Arterial blood
39
182
2.24
4.97
5.7
8.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
523
1.76
4.93
1.8
1.6
nmol/l
1233.7
1175.8
0.20
73
398
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
32
4.15
4.92
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
112
745
1.66
4.89
1.4
1.3
iu/ml
23.7
31.2
0.42
30
244
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
107
2.61
4.88
1.7
1.8
g/l
2.9
3.1
0.44
19
87
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
198
2.17
4.81
1.6
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
350
3028
1.58
4.66
4.2
3.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
69
2.98
4.66
1.4
2.8
—
—
—
0
0
(3044889) 12 lead EKG panel
314
2657
1.53
4.57
3.8
3.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
155
1132
1.55
4.54
3.0
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
199
1538
1.50
4.46
3.3
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
198
2.11
4.43
2.3
2.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
12
7.62
4.37
1.0
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
59
338
1.85
4.33
7.6
10.1
mmol/l
1.6
1.2
0.60
48
261
(3048689) Calprotectin [Mass/mass] in Stool
85
543
1.69
4.30
2.2
2.4
ug/g
120.5
120.9
0.00
66
423
(3052851) Hemolysis interference index of Serum or Plasma
26
108
2.49
4.30
2.2
2.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
31
3.94
4.28
2.2
1.7
mg/l
13.8
14.8
—
5
10
(3001122) Ferritin [Mass/volume] in Serum or Plasma
227
1816
1.48
4.22
3.3
2.7
ug/l
98.6
112.9
0.37
214
1697
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
27
4.15
4.18
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
27
4.15
4.18
1.1
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
13
7.03
4.18
1.6
1.2
u/l
9.7
14.5
—
9
13
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
35
169
2.16
4.13
2.0
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
20
75
2.74
4.04
1.0
1.1
—
13.5
—
0
8
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
86
563
1.64
3.95
1.7
2.7
mmol/l
2.4
2.4
0.17
72
487
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
44
240
1.92
3.76
1.6
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
176
1365
1.46
3.72
3.0
3.6
u/l
31.1
32.4
0.23
171
1304
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
40
3.31
3.65
1.5
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
69
436
1.68
3.63
1.7
2.3
%
21.9
24.9
1.06
61
384
(40761511) CBC panel - Blood by Automated count
455
4297
2.22
3.60
15.4
10.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
105
737
1.54
3.59
1.5
1.4
nmol/l
21.2
21.4
0.06
95
628
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
112
798
1.53
3.58
1.4
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
119
2.25
3.51
1.3
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
78
519
1.60
3.35
1.8
2.2
umol/l
12.6
14.3
1.31
71
477
(3026389) Candida sp identified in Specimen by Organism specific culture
14
48
2.97
3.32
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
48
2.97
3.32
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
43
3.08
3.27
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
43
3.08
3.27
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
96
674
1.53
3.27
1.9
1.6
pmol/l
436.0
20069041.7
0.79
84
583
(3009542) Hematocrit [Volume Fraction] of Blood
418
3869
1.64
3.22
17.5
12.2
%
41.2
40.8
0.46
325
3066
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
49
2.91
3.21
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
28
3.63
3.21
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
67
435
1.63
3.18
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
46
272
1.76
3.08
1.6
2.2
e9/l
4.3
4.0
0.50
40
230
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
34
3.29
3.07
1.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
34
3.29
3.07
1.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
34
3.29
3.07
1.3
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
161
1.99
3.07
9.8
14.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
16
5.07
3.06
1.6
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
21
4.35
3.01
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
21
4.35
3.01
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
21
4.35
3.01
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
21
4.35
3.01
1.3
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
17
4.77
2.93
1.6
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
123
2.09
2.87
2.8
2.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
72
0.00
2.80
0.0
1.3
—
3.2
—
0
64
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
393
3619
1.48
2.76
5.6
5.0
mmol/mol
39.5
39.0
0.38
375
3415
(40757373) Influenza virus identified in Isolate
5
6
8.40
2.75
1.6
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
14
5.06
2.73
1.0
1.1
miu/ml
1124.9
1646.9
—
7
14
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
37
3.02
2.71
1.5
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
19
4.26
2.69
1.6
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
329
2942
1.38
2.68
3.3
3.1
u/l
41.1
44.0
0.39
313
2798
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
24
3.80
2.68
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1015
1.40
2.65
1.8
1.7
mmol/l
1.3
1.4
0.88
107
866
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
49
2.70
2.64
1.3
1.3
nmol/l
0.5
0.5
0.07
13
43
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
15
4.72
2.60
1.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
15
4.72
2.60
1.4
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
15
4.72
2.60
1.4
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
38
2.94
2.59
1.5
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
56
2.55
2.55
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
33
3.07
2.54
1.5
3.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
38
226
1.74
2.52
1.1
1.1
—
106.0
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
9
26
3.51
2.49
1.8
2.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
69
479
1.51
2.47
1.8
2.2
g/l
2.5
2.4
0.92
63
447
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
64
440
1.52
2.40
2.0
2.8
umol/l
4.5
8.4
2.40
55
382
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
8
6.30
2.37
1.0
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
91
2.13
2.36
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
28
3.26
2.32
2.2
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
59
2.41
2.31
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
41
2.72
2.29
3.2
2.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
13
4.66
2.28
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
13
4.66
2.28
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
13
4.66
2.28
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
13
4.66
2.28
1.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
242
1.67
2.24
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
9
5.60
2.22
1.0
2.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
9
5.60
2.22
1.2
1.0
—
—
—
0
0
(3019225) pH of Specimen
48
316
1.58
2.19
3.6
3.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
24
3.37
2.19
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
34
206
1.70
2.14
3.2
2.7
ng/l
107.1
132.8
0.18
28
186
(3037121) Protein [Mass/volume] in Urine
24
132
1.86
2.07
3.8
3.7
g/l
0.1
0.2
—
7
59
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
44
2.54
2.02
1.2
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
26
3.11
2.02
1.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
38
2.67
2.02
1.2
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
32
2.85
2.01
1.3
2.1
—
—
—
0
0
(4027681)
9
32
2.85
2.01
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
187
0.42
1.97
1.4
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
71
2.15
1.94
2.9
2.4
mmol/l
24.1
23.7
0.14
15
62
(1002224) Polysomnography panel
36
228
1.63
1.94
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
51
352
1.50
1.91
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
22
3.21
1.88
1.1
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
22
3.21
1.88
1.0
1.8
%
13.3
12.6
—
7
22
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
22
3.21
1.88
1.1
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
254
1.58
1.88
6.9
8.6
—
—
—
0
0
(3002256) Pathology report gross observation
64
465
1.43
1.85
1.2
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
6
17
3.56
1.84
1.8
1.1
umol/l
1.3
5.5
—
6
17
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
17
3.56
1.84
2.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
118
952
1.32
1.80
3.5
3.3
mg/l
697.2
284.6
0.27
71
616
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
150
0.39
1.80
1.7
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
150
0.39
1.80
1.7
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
151
0.39
1.80
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
151
0.39
1.80
1.7
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
29
2.79
1.80
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
41
2.47
1.76
1.0
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
118
956
1.31
1.74
2.8
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
118
1.82
1.73
2.3
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
5
13
3.87
1.72
2.8
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
48
2.32
1.71
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
196
1699
1.26
1.69
2.5
2.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
42
2.41
1.68
1.2
1.3
nmol/l
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
409
3880
1.37
1.67
4.5
4.0
mmol/l
5.7
5.8
2.77
389
3597
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
150
1.70
1.67
2.9
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
14
3.60
1.62
1.8
1.7
ug/l
0.2
1.1
—
5
14
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
463
1.39
1.56
4.2
3.9
%
31.7
31.7
0.01
49
320
(3020682) Albumin/Creatinine [Ratio] in Urine
122
1008
1.28
1.55
4.5
4.1
mg/mmol
6.1
10.9
0.74
74
639
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
281
0.55
1.54
1.4
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
22
2.75
1.44
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
104
850
1.29
1.43
3.5
3.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.3
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
409
3904
1.33
1.39
4.0
3.7
mmol/l
1.3
1.3
0.04
386
3656
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
112
1.73
1.37
2.0
2.0
iu/l
4.7
6.2
—
6
39
(40761535) Cells panel - Urine sediment
40
285
1.44
1.32
3.8
3.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
130
1102
1.25
1.32
3.5
3.2
mmol/l
8.1
8.2
0.09
114
933
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
425
4087
1.36
1.31
4.8
4.4
mmol/l
3.0
2.9
0.88
405
3827
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
31
211
1.50
1.29
1.5
1.8
mg/l
3.8
3.7
0.05
23
149
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
421
4045
1.34
1.29
4.6
4.1
mmol/l
4.9
4.8
1.66
401
3814
(3035933) Granulocytes/100 leukocytes in Blood
5
18
2.80
1.29
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
18
2.80
1.29
1.0
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
12
63
1.93
1.23
3.0
2.4
kpa
9.2
8.4
0.93
12
58
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
206
1.49
1.21
1.5
2.3
u/l
2956.5
2672.8
—
6
91
(3037756) Immunofixation for Serum or Plasma
12
64
1.90
1.19
1.8
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
129
0.46
1.18
1.3
1.6
—
—
—
0
0
(44790047)
8
40
2.02
1.12
1.6
1.7
—
—
—
0
0
(44790049)
8
40
2.02
1.12
1.6
1.7
—
—
—
0
0
(44790048)
8
40
2.02
1.12
1.6
1.7
—
—
—
0
0
(44806118)
8
40
2.02
1.12
1.6
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
36
261
1.41
1.11
2.2
3.4
mmol/l
2.9
2.3
0.35
30
214
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
227
1.44
1.11
1.1
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
162
0.55
1.10
1.6
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
81
1.75
1.10
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
21
2.40
1.09
2.2
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
65
519
1.29
1.09
3.2
2.6
e6/l
3.6
2.7
0.34
34
267
(3024928) Oxygen saturation in Venous blood
11
59
1.88
1.08
1.9
3.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
418
4032
1.29
1.07
4.4
4.0
mmol/l
1.5
1.5
1.93
398
3780
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
121
0.49
1.06
1.7
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
7
34
2.07
1.03
1.3
1.2
mosm/kgh2o
275.1
280.1
—
7
26
(3022217) INR in Platelet poor plasma by Coagulation assay
48
373
1.32
0.99
13.4
15.1
inr
1.4
1.2
—
7
57
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
347
1.33
0.98
2.5
2.4
u/l
54.1
32.1
0.52
36
292
(3051611) Lipemic interference index of Serum or Plasma
7
36
1.96
0.97
2.3
3.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
32
0.00
0.95
0.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
85
1.67
0.95
1.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
120
0.49
0.94
1.7
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
86
1.65
0.92
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
28
2.16
0.92
2.5
3.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
28
2.16
0.92
2.5
2.1
—
—
—
0
0
(4024509)
6
28
2.16
0.92
2.7
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
42
1.92
0.89
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
79
1.66
0.89
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
67
554
1.24
0.87
3.0
2.5
e6/l
0.6
0.9
1.17
36
302
(3049717) Cytology report of Urine Cyto stain
16
105
1.54
0.82
2.2
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
172
1.42
0.82
2.0
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
73
1.66
0.82
2.8
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
73
1.66
0.82
2.6
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
109
955
1.18
0.80
3.9
3.9
ug/l
1.3
2.0
1.10
99
870
(3002523) Influenza virus A Ag [Presence] in Specimen
15
98
1.55
0.79
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
98
1.55
0.79
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
123
0.56
0.79
1.6
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
98
0.51
0.78
1.4
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
123
1.48
0.78
1.1
1.1
—
—
—
0
0
(4034850)
7
125
0.55
0.78
26.3
8.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
34
262
1.32
0.77
2.8
8.0
mmol/l
8.7
7.8
0.34
34
250
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
124
1.47
0.76
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
124
1.47
0.76
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
25
2.01
0.73
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
60
1.68
0.72
1.1
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
81
700
1.19
0.70
2.0
2.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
49
587
0.82
0.66
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
112
1.44
0.64
1.1
1.3
—
—
—
0
0
(4198724)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
52
1.55
0.59
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
230
0.73
0.58
1.3
2.8
u/ml
14.7
43.2
1.83
17
223
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
13
89
1.47
0.58
3.2
4.1
—
2.1
—
0
16
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
504
0.82
0.58
1.8
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
35
1.72
0.58
1.7
3.1
nmol/l
1.8
3.0
—
6
35
(3005570) Glucose [Moles/volume] in Urine
6
35
1.72
0.58
3.7
2.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
65
1.55
0.56
1.3
1.8
%
13.4
13.1
—
10
65
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
65
1.55
0.56
1.6
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
576
1.17
0.53
2.4
2.5
ug/l
0.5
0.7
2.75
39
329
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
64
1.41
0.51
1.2
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
190
1.28
0.49
1.4
1.3
miu/ml
157.4
253.1
—
9
100
(3032773) Endomysium IgG Ab [Titer] in Serum
7
46
1.53
0.48
1.3
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
137
1.33
0.48
1.2
1.1
—
10.5
—
0
20
(4268621)
7
47
1.50
0.47
2.6
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
48
1.47
0.47
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
319
0.80
0.46
2.6
4.4
ug/l
2.9
6.9
1.65
19
258
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
50
1.41
0.45
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
51
1.38
0.44
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
51
1.38
0.44
1.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
51
1.38
0.44
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
51
1.38
0.44
1.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
51
1.38
0.44
1.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
166
1.28
0.44
2.2
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
110
1195
0.90
0.44
1.5
1.5
—
—
—
0
0
(4094501)
14
104
1.36
0.43
1.1
1.1
—
—
—
0
0
(4035726)
36
304
1.20
0.43
1.3
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
2.8
mu/l
25.8
19.8
—
5
31
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
158
1.28
0.42
1.2
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
57
1.41
0.42
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
16
0.00
0.41
0.0
5.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
306
1.19
0.41
3.5
2.5
ml/min/173m2
78.6
72.2
0.44
15
137
(3020891) Body temperature
16
123
1.31
0.41
9.8
4.8
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
17
0.00
0.40
0.0
23.3
—
7.0
—
0
12
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
60
1.34
0.40
1.0
3.3
—
3121.2
—
0
9
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
71
639
1.13
0.39
1.8
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
61
1.32
0.39
1.0
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
15
115
1.31
0.39
1.2
2.9
mg/l
1.1
1.4
2.04
15
106
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
60
536
1.14
0.38
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
432
1.15
0.37
6.4
5.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
72
1.40
0.37
1.1
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
79
0.63
0.35
4.0
3.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
164
1.23
0.33
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
754
0.90
0.32
1.6
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
22
185
1.20
0.29
2.5
2.4
e6/l
0.1
0.1
0.26
22
179
(3025130) Human papilloma virus identified in Specimen
8
65
1.23
0.27
2.9
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
132
1.22
0.26
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
513
1.10
0.25
1.6
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
112
1182
0.93
0.25
2.0
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
87
1.27
0.24
1.4
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
82
768
1.08
0.24
3.5
3.5
%
17.9
21.3
1.15
28
298
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
38
1.32
0.23
1.2
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
31
346
0.89
0.22
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
2.5
—
135.4
—
0
11
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
0.7
—
0
8
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
311
0.89
0.19
2.0
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
204
1.13
0.18
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
68
1.18
0.16
1.1
1.1
%
123.5
115.8
—
8
63
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
86
901
0.94
0.16
1.9
2.0
—
—
—
0
0
(4306422)
8
72
1.11
0.16
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
59
557
1.07
0.15
1.6
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
118
0.84
0.14
1.7
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
33
305
1.09
0.14
1.7
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
185
1810
1.04
0.12
3.4
3.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
137
0.87
0.12
1.5
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
26
240
1.09
0.11
2.2
2.3
ug/l
2.4
7.9
3.88
26
218
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
86
1.17
0.11
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
222
1.09
0.10
3.1
2.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
106
1.14
0.10
1.1
1.4
ug/g
363.9
308.6
—
7
62
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
14
126
1.11
0.09
1.4
2.1
%
93.7
92.1
0.10
14
116
(3027944) Amphetamines [Presence] in Urine
22
236
0.93
0.08
4.5
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
88
1.14
0.08
1.1
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
76
1.05
0.07
1.3
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
76
1.05
0.07
1.0
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
103
0.87
0.06
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
20
188
1.07
0.05
5.3
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
219
1.05
0.04
4.1
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
160
0.94
0.04
3.6
2.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
139
0.93
0.03
3.8
3.4
%
50.3
52.5
0.08
13
139
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
38
391
0.97
0.03
2.1
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
260
1.04
0.03
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
85
862
0.98
0.03
3.1
3.3
kg/l
1.0
1.0
—
8
108
(3028300) Cannabinoids [Presence] in Urine
23
239
0.96
0.02
4.5
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
237
0.97
0.01
4.1
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
104
1.06
0.01
6.9
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
236
0.97
0.00
4.7
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
645
1.01
0.00
1.5
1.8
%
1.5
1.4
0.37
59
583
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
178
1.01
0.00
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
189
1.01
0.00
1.5
1.9
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
4.0
—
0.4
—
0
5
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
99
0.91
0.00
1.2
1.2
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.4
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
1.8
—
0
9
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.1
—
1.3
—
0
8
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
52.4
—
0
7
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.1
—
1.2
—
0
9
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.5
—
6852.6
—
0
8
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
160
1.00
0.00
2.7
2.8
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
55.0
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
74
0.95
0.00
1.7
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint RX_ASTMA_BIOL and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have RX_ASTMA_BIOL.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: RX_ASTMA_BIOL – Biological medicines for asthma
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data